TTC23 and glioblastoma: Functional validation was performed in GBM cell models to assess migration, apoptosis, cell viability, and clonogenic potential under TTC23 perturbation with or without CPZ exposure.<h4>Results</h4>Integrated CPZ-GBM intersection analysis and network-based prognostic modeling consistently prioritized TTC23 as a clinically relevant candidate.